ZM-241,385
ZM-241,385 is a potent and selective adenosine receptor antagonist, specifically targeting the adenosine A2A receptor. It is widely used in pharmacological research to study the role of adenosine receptors in various physiological and pathological processes.
Chemical Properties[edit | edit source]
ZM-241,385 is a synthetic compound with a complex chemical structure. It is known for its high affinity and selectivity towards the adenosine A2A receptor, making it a valuable tool in neuroscience and cardiovascular research.
Mechanism of Action[edit | edit source]
ZM-241,385 functions by binding to the adenosine A2A receptor, thereby inhibiting the action of adenosine, a neurotransmitter that plays a crucial role in regulating neurotransmission, vasodilation, and immune response. By blocking this receptor, ZM-241,385 can modulate various physiological responses, making it useful in studying conditions such as Parkinson's disease, ischemia, and inflammation.
Applications in Research[edit | edit source]
Neuroscience[edit | edit source]
In neuroscience, ZM-241,385 is used to investigate the role of adenosine A2A receptors in neurodegenerative diseases like Parkinson's disease. Studies have shown that antagonism of these receptors can have neuroprotective effects, potentially offering therapeutic benefits.
Cardiovascular Research[edit | edit source]
ZM-241,385 is also employed in cardiovascular research to explore its effects on vasodilation and myocardial ischemia. By blocking the adenosine A2A receptor, researchers can better understand the mechanisms underlying cardiovascular diseases and develop new therapeutic strategies.
Immunology[edit | edit source]
In the field of immunology, ZM-241,385 is used to study the role of adenosine A2A receptors in modulating the immune response. This research is crucial for developing treatments for inflammatory diseases and autoimmune disorders.
Safety and Handling[edit | edit source]
As with any research chemical, proper safety protocols must be followed when handling ZM-241,385. It should be used in a controlled laboratory environment, and appropriate personal protective equipment (PPE) should be worn to prevent exposure.
See Also[edit | edit source]
References[edit | edit source]
External Links[edit | edit source]
-
 | This medical article is a stub. You can help WikiMD by expanding it. |
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD
